This week, Beyond Biotech examined the clinical and commercial challenges facing developers of childhood myopia treatments, following Theialife's efforts to bring a potential therapy to market. The episode highlighted the tension between addressing a growing public health concern and navigating the regulatory and reimbursement hurdles that slow pediatric drug development. The conversation underscored how even promising treatments face substantial obstacles before reaching the patients who need them.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Previous Weeks
This Week in Beyond Biotech (Sep 14 - Sep 20, 2026)
1 episode · Sep 14 – Sep 20
This Week in Beyond Biotech (Sep 7 - Sep 13, 2026)
1 episode · Sep 7 – Sep 13
This Week in Beyond Biotech (Aug 31 - Sep 6, 2026)
1 episode · Aug 31 – Sep 6
This Week in Beyond Biotech (Aug 24 - Aug 30, 2026)
1 episode · Aug 24 – Aug 30
This Week in Beyond Biotech (Aug 17 - Aug 23, 2026)
1 episode · Aug 17 – Aug 23
This Week in Beyond Biotech (Aug 10 - Aug 16, 2026)
1 episode · Aug 10 – Aug 16
This Week in Beyond Biotech (Aug 3 - Aug 9, 2026)
1 episode · Aug 3 – Aug 9
This Week in Beyond Biotech (Jul 27 - Aug 2, 2026)
1 episode · Jul 27 – Aug 2
This Week in Beyond Biotech (Jul 20 - Jul 26, 2026)
1 episode · Jul 20 – Jul 26
This Week in Beyond Biotech (Jul 13 - Jul 19, 2026)
1 episode · Jul 13 – Jul 19
This Week in Beyond Biotech (Jul 6 - Jul 12, 2026)
1 episode · Jul 6 – Jul 12
All Beyond Biotech Summaries
Browse every episode with AI-generated summaries, key insights, and more.
Start FreeNo credit card required • Free tier available